Financials
Financial year 2025
Gross margin
€ 0
Profit
Healthy€ 183,245
▼ 46% vs 2024
Debts
Low€ 19,198
▼ 20% vs 2024
BASF PHARMA BELGIUM from Antwerpen, company number BE0845445466, closed financial year 2025 with a result of € 183,245 after tax. For that financial year BASF PHARMA BELGIUM recorded a gross margin of € 0 and equity of € 11.6 million. Compared with financial year 2024, the result moved from € 337,113 to € 183,245. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 28, 2026.
What happened at BASF PHARMA BELGIUM?
What happened at BASF PHARMA BELGIUM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Jan Remeysen stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 183,245 (▼ 46% vs 2024). Source: NBB ↗
- Bart Goossens stepped down as director. NBB
- Bart Goossens became a director. NBB
- Stefanie Demming stepped down as director. NBB
- Jan Remeysen became a director. NBB
- Stefanie Demming became a director. NBB
- New establishment in Antwerpen. KBO
In short
From € 28,532 loss in 2021 to € 183,245 profit in 2025.
Best year ever: 2024, with € 337,113 profit.
Pays suppliers within 105 days on average.
A new publication or filing at BASF PHARMA BELGIUM? We notify you, reason included.
Follow BASF PHARMA BELGIUMNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
The shares are held by BASF Antwerpen NV (100%) and BASF Belgium Coordination Center Comm.V (0%). It owns 100% of BASF Pharma (Callanish) Ltd. itself.
Directors
According to the 2025 annual accounts
Jan Remeysen
Director
Also active at: VLAAMS ECONOMISCH VERBOND, Vlaams Netwerk van Ondernemingen, ACTA +2 more
since 2025 · until 2028
since 2026 · until 2026
Stefanie Demming
Director
since 2025 · until 2026
Shareholders
Participations
BASF Pharma (Callanish) Ltd.
100%
Establishments
Establishment units
Physical locations of this company
Scheldelaan 600
2040 Antwerpen
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 11 companies are registered at this address.
BASF Antwerpen same network
€ 5,687.2 million revenue · 2025
BASF Personeelsclub
BASF Werknemers en Tariefbedienden
BASF VOORZORGSFONDS
BASF Kaderleden en Directie
+6 more
Details
- Company number
- 0845.445.466
- VAT number
- BE 0845.445.466
- Registered office
- Scheldelaan 600, 2040 Antwerpen
- Names & denominations
- BASF PHARMA BELGIUM
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 23 April 2012
- Peppol
- Not registered